CDC Website CDC Website

To Join the NPIN community or

You are here

Antiviral Drugs

Guide for HIV/AIDS Clinical Care

NPIN admin's picture
This manual for clinicians provides guidelines for clinical care of persons with HIV/AIDS. This updated version incorporates many new insights, but the time-tested format has been retained – easy access to crucial facts for a busy clinician. The guide touches on every topic facing people with HIV and their caregivers.

A Guide to: Understanding Hepatitis C 2015

NPIN admin's picture
This guide is designed to help patients understand and manage Hepatitis C Virus (HCV). The guide states that HCV is the leading reason for liver transplants in the U.S. The guide covers HCV transmission, disease progression, symptoms, diagnosis, and treatment options and considerations.

Updated Interim Guidance–HIV-Infected Adults and Adolescents: Considerations for Clinicians Regarding Swine-Origin Influenza A (H1N1) Virus

NPIN admin's picture
This Web site provides interim guidance for clinicians who treat immune compromised persons, including HIV-infected adults and adolescents. The page explains that persons with low CD4 cell counts or AIDS can experience more severe complications of seasonal influenza, and possibly HIV-infected adults and adolescents are at higher risk for swine-origin influenza complications.

FDA May 23, 2011 Teleconference Briefing on Direct Acting Antivirals, Victrelis (boceprevir) and Incivek (telaprevir) Transcript

NPIN admin's picture
This teleconference briefing transcript recorded a briefing on direct acting antivirals, victrelis (boceprevir) and incivek (telaprevir). The purpose of the call was to update participants about two direct acting anti-viral drugs to treat hepatitis C discussed at a meeting of the FDA Antiviral Advisory Committee on April 27 and 28, 2011. The briefing was a response to the comments from the meeting. With the moderator Richard Klein in the room are Dr. Debra Birnkrant, Director of the FDA’s Division of Antiviral Products, and Dr. Jeffrey Murray, Deputy Director of the Division.

Seguimiento de un régimen de tratamiento para la infección por el VIH

NPIN admin's picture
This fact sheet discusses the importance of adhereing to an HIV treatment regimen. It states that adherence starts with the decision to follow a daily routine before actually taking any medications. It encourages discussing the importance of regimen maintenance with a physician. The sheet also provides helpful strategies to stay on track and what to do if adherence is difficult. A glossary of terms is included.

Following an HIV Treatment Regimen

NPIN admin's picture
This fact sheet discusses the importance of adhereing to an HIV treatment regimen. It states that adherence starts with the decision to follow a daily routine before actually taking any medications. It encourages discussing the importance of regimen maintenance with a physician. The sheet also provides helpful strategies to stay on track and what to do if adherence is difficult. A glossary of terms is included.

Medicamentos contra el VIH aprobados por la FDA

NPIN admin's picture
This fact sheet discusses what anti-HIV medications have been approved by the US Food and Drug Administration (FDA). It lists the recommended antiretroviral therapies (ART). The sheet also explains that ART is a combination of anti-HIV medications, which are to be taken daily, and if taken correctly, people with HIV live longer, healthier lives. A table of all approved drugs is included.

FDA-Approved Anti-HIV Medications

NPIN admin's picture
This fact sheet discusses what anti-HIV medications have been approved by the US Food and Drug Administration (FDA). It lists the recommended antiretroviral therapies (ART). The sheet also explains that ART is a combination of anti-HIV medications, which are to be taken daily, and if taken correctly, people with HIV live longer, healthier lives. A table of all approved drugs is included.
Subscribe to RSS - Antiviral Drugs